Patent · US Active

Reduced-viscosity concentrated protein formulations

US10166293B2 · kind B2 · utility

8Cited by

42References

58Claims

0Family size

Assignees

Genentech, Inc. · US
Novartis AG · CH

Inventors

Jun Liu · South San Francisco, US
Steven J. Shire · San Mateo, US

Key dates

Filing date	Mar 7, 2014
Grant date	Jan 1, 2019
Priority date	—
Expiry date	Mar 7, 2034

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K2039/505
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present application concerns concentrated protein formulations with reduced viscosity, which are particularly suitable for subcutaneous administration. The application further concerns a method for reducing the viscosity of concentrated protein formulations.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.